Immutep Limited
Immutep Limited (IMMP) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
immp · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Immutep Limited (IMMP) measures how much investors pay for each dollar of the company's trailing earnings. IMMP's current PE ratio of N/A is calculated by dividing its stock price of $0.37 by its TTM earnings per share of -$0.06.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2008 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Immutep LimitedYou IMMP | $54M | N/A | — | -$0.06 |
 Achieve Life Sciences, Inc. ACHV | $563M | N/A | — | -$1.25 |
 Allogene Therapeutics, Inc. ALLO | $451M | N/A | — | -$0.87 |
 Cabaletta Bio, Inc. CABA | $522M | N/A | — | -$1.64 |
 Candel Therapeutics, Inc. CADL | $467M | N/A | — | -$0.72 |
 Capricor Therapeutics, Inc. CAPR | $1.2B | N/A | — | -$2.26 |
 Editas Medicine, Inc. EDIT | $259M | N/A | — | -$1.80 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-0.42 | — | |
2024-06-30 FY2024 | — | $-0.36 | — | |
2023-06-30 FY2023 | — | $-0.44 | — | |
2022-06-30 FY2022 | — | $-0.37 | — | |
2021-06-30 FY2021 | — | $-0.49 | — | |
2020-06-30 FY2020 | — | $-0.33 | — | |
2019-06-30 FY2019 | — | $-0.38 | — | |
2018-06-30 FY2018 | — | $-0.30 | — | |
2017-06-30 FY2017 | — | $-0.22 | — | |
2016-06-30 FY2016 | — | $-1.45 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Immutep Limited (IMMP) measures how much investors pay for each dollar of the company's trailing earnings. IMMP's current PE ratio of N/A is calculated by dividing its stock price of $0.37 by its TTM earnings per share of -$0.06.
Frequently asked questions
IMMP pe ratio · 6 questionsIMMP's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.37 and TTM EPS of -$0.06. Data sourced from Financial Modeling Prep via IMMP's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Immutep Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09